Delos Reyes, Edmond S.

HRN: 07-10-43  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/29/2024
12/08/2024
IV
600
Q6
CELLULITIS
Waiting Final Action 
11/29/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/29/2024
12/08/2024
IV
2.25
Q6
CELLULITIS
Waiting Final Action 
11/29/2024
MUPIROCIN 2%, 15G (TUBE)
11/29/2024
12/05/2024
TOPICAL
2%
BID
CELLULITIS
Waiting Final Action 
12/13/2024
CO-AMOXICLAV 625MG (TAB)
12/13/2024
12/20/2024
ORAL
625mg
TID
DM Foot
Waiting Final Action 
12/13/2024
CLINDAMYCIN 300MG (CAP)
12/13/2024
12/27/2024
ORAL
300mg
TID
DM Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: